Quantum Biopharma Ltd.

Listed Company
QNTMCIK 0001771885NasdaqNon-AcceleratedEmerging GrowthPharmaceutical PreparationsA6CAFY ends Dec 31
Period
FY 2025
Revenue
Net Income
Total Assets
$11.16M
Equity
Shares Out
12
Op. Cash Flow

Business

Quantum Biopharma Ltd. operates as a biopharmaceutical holding and investment company that acquires, controls and manages biotechnology assets and related subsidiaries. It structures and administers IP license agreements, loans and capital transactions and supports subsidiary operations through licensing, financing and corporate governance arrangements. Key business components include its controlled subsidiary Celly Nu, its FSD Strategic Investments lending portfolio, and corporate financing activities such as private placements and shareholder agreements. The company conducts its activities through subsidiary relationships, loan and license structures, and private capital markets.

Summary from filing dated 2025-03-28

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income
Total assets$11.16M
Total liabilities$6.06M
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro